B1AX34 Stock Overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 2/6 |
Baxter International Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$105.60 |
52 Week High | US$120.00 |
52 Week Low | US$80.00 |
Beta | 0.63 |
1 Month Change | 0% |
3 Month Change | 10.00% |
1 Year Change | -9.62% |
3 Year Change | -55.14% |
5 Year Change | n/a |
Change since IPO | -44.65% |
Recent News & Updates
Recent updates
Shareholder Returns
B1AX34 | BR Medical Equipment | BR Market | |
---|---|---|---|
7D | -1.1% | 2.1% | 0.4% |
1Y | -9.6% | -1.2% | 13.9% |
Return vs Industry: B1AX34 underperformed the BR Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: B1AX34 underperformed the BR Market which returned 14.9% over the past year.
Price Volatility
B1AX34 volatility | |
---|---|
B1AX34 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.5% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 8.8% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: B1AX34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine B1AX34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1931 | 60,000 | Joe Almeida | www.baxter.com |
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Baxter International Inc. Fundamentals Summary
B1AX34 fundamental statistics | |
---|---|
Market cap | R$107.55b |
Earnings (TTM) | -R$391.21m |
Revenue (TTM) | R$76.25b |
1.4x
P/S Ratio-274.3x
P/E RatioIs B1AX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
B1AX34 income statement (TTM) | |
---|---|
Revenue | US$14.81b |
Cost of Revenue | US$9.15b |
Gross Profit | US$5.66b |
Other Expenses | US$5.74b |
Earnings | -US$76.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
Earnings per share (EPS) | -0.15 |
Gross Margin | 38.22% |
Net Profit Margin | -0.51% |
Debt/Equity Ratio | 162.1% |
How did B1AX34 perform over the long term?
See historical performance and comparison